Animal studies on neuropathic pain: The role of cytokines and cytokine receptors in pathogenesis and therapy;Tierexperimentelle untersuchungen bei neuropathischem schmerz: Pathogene und therapeutische bedeutung von zytokinen und zytokinrezeptoren

Schmerz

Volumn 13, Issue 5, 1999, Pages 315-323

  Sommer, Claudia ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Chronic pain; Cytokines; Neuropathic pain

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CYTOKINE RELEASE; HYPERALGESIA; MEDIATOR RELEASE; NEUROPATHY; NONHUMAN; PATHOGENESIS;

EID: 0032710457     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004820050238     Document Type: Article

References (41)

1. Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL (1992) Tumor necrosis factor production in patients with leprosy. Infect Immun 60:1441-1446
2. Bennett G (1994) Neuropathic pain. In: Wall PD, Melzack R (ed) Textbook of pain. Churchill Livingstone, Edinburgh London New York, pp 201-224
3. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107
4. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63
5. Cunha F, Poole S, Lorenzetti B, Ferreira S (1992) The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660-664
6. Devor M (1996) Pain mechanisms. Neuroscientist 2:233-244
7. Dixon W (1965) The up-and-down method for small samples. J Am Statist Assoc 60:967-978
8. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110
9. Ferreira S, Lorenzetti B, Bristow A, Poole S (1988) Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698-700
10. George A, Schmidt C, Toyka KV, Sommer C (1999) Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol in press
11. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802
12. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88
13. Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG, Guthrey DS (1995) Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 10:527-543
14. Herzberg U, Eliav E, Dorsey JM, Gracely RH, Kopin IJ (1997) NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport 8:1613-1618
15. Kagan BL, Baldwin RL, Munoz D, Wisnieski BJ (1992) Formation of ion-permeable channels by tumor necrosis factor-alpha. Science 255:1427-1430
16. Kingery WS (1997) A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73:123-139
17. Lewin GR, Mendell LM (1993) Nerve growth factor and nociception. Trends Neurosci 16:353-358
18. Lindholm D, Heumann R, Meyer M, Thoenen H (1987) Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330:658-659
19. Mohler KA, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, Kronheim SR, Petersen M, Gerhart M, Kozlosky CJ, March CJ, Black RA (1994) Protection against a lethal dose of endoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218-220
20. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177:1675-1680
21. Nicol GD, Lopshire JC, Pafford CM (1997) Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J Neurosci 17:975-982
22. Perkins MN, Kelly D (1994) Interleukin-1b induced desArg9 bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology 33:657-660
23. Redford EJ, Hall SM, Smith KJ (1995) Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 118:869-878
24. Reichert F, Levitzky R, Rotshenker S (1996) Interleukin 6 in intact and injured mouse peripheral nerves. Eur J Neurosci 8:530-535
25. Ren K, Thomas DA, Dubner R (1995) Nerve growth factor alleviates a painful peripheral neuropathy in rats. Brain Res 699:286-292
26. Rotshenker S, Aamar S, Barak V (1992) Interleukin-1 activity in lesioned peripheral nerve. J Neuroimmunol 39:75-80
27. Sheehan KC, Ruddle NH, Schreiber RD (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 142:3884-3893
28. Sheehan KC, Pinckard JK, Arthur CD, Dehner LP, Goeddel DV, Schreiber RD (1995) Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J Exp Med 181:607-617
29. Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6:303-306
30. Sommer C, Marziniak M (1996) Experimental painful mononeuropathy: inhibitors of TNF-γ-production induce a decrease in hyperalgesia and an increase of spinal met-enkephalin. Soc Neurosci Abs 22:511
31. Sommer C, Schäfers M (1998) Painful mononeuropathy in C57BL/Wld mice with delayed Wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res 784:154-162
32. Sommer C, Lalonde A, Heckman MH, Rodriguez M, Myers RR (1995) Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J Neuropathol Exp Neurol 54:635-643
33. Sommer C, Schmidt C, George A, Toyka KV (1997) A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci Lett 237:45-48
34. Sommer C, Marziniak M, Myers RR (1998) The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain 74:83-91
35. Sommer C, Schmidt C, George A (1998) Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 151:138-142
36. Sorkin LS, Xiao WH, Wagner R, Myers RR (1997) Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255-262
37. Stoll G, Jung S, Jander S, Meide Pvd, Hartung H-P (1993) Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 45:175-182
38. Vandenabeele P, Declerq W, Beyart R, Fiers W (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5:392-399
39. Wagner R, Myers RR (1996) Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73:625-629
40. Wells M, Racis SJ, Vaidya U (1992) Changes in plasma cytokines associated with peripheral nerve injury. J Neuroimmunol 39:261-268
41. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110